
Outset Medical OM
$ 4.1
0.49%
Annual report 2025
added 02-13-2026
Outset Medical Total Assets 2011-2026 | OM
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Outset Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 264 M | 276 M | 314 M | 400 M | 463 M | 404 M | 88.4 M | 151 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 463 M | 88.4 M | 295 M |
Quarterly Total Assets Outset Medical
| 2025-Q3 | 2024-Q4 | 2024-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 277 M | 276 M | - | - | - | - | 432 M | 463 M | 489 M | 505 M | 380 M | 404 M | 404 M | 404 M | 404 M | 88.4 M | 88.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 505 M | 88.4 M | 355 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
4.32 B | $ 11.94 | -1.08 % | $ 1.61 B | ||
|
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.07 | -3.3 % | $ 257 M | ||
|
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | ||
|
Electromed
ELMD
|
53.8 M | $ 23.78 | 0.72 % | $ 201 M | ||
|
Bruker Corporation
BRKR
|
5.81 B | $ 36.67 | -0.19 % | $ 5.46 K | ||
|
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | ||
|
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | ||
|
Globus Medical
GMED
|
5.3 B | $ 90.0 | 1.58 % | $ 12.2 B | ||
|
FONAR Corporation
FONR
|
199 M | $ 18.58 | -0.11 % | $ 122 M | ||
|
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.83 | -3.68 % | $ 1.11 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.33 | 0.21 % | $ 719 M | ||
|
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.4 | -1.73 % | $ 127 M | ||
|
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | ||
|
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.03 | 3.35 % | $ 17.4 M | ||
|
Integer Holdings Corporation
ITGR
|
3.41 B | $ 85.11 | -0.61 % | $ 2.96 B | ||
|
Align Technology
ALGN
|
6.21 B | $ 166.87 | -2.91 % | $ 12.5 B | ||
|
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | ||
|
AxoGen
AXGN
|
222 M | $ 30.99 | -5.06 % | $ 1.43 B | ||
|
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.76 | -1.13 % | $ 370 M | ||
|
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | ||
|
LENSAR
LNSR
|
71.4 M | $ 5.63 | -4.41 % | $ 67.3 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M | ||
|
Medtronic PLC
MDT
|
91.7 B | $ 86.42 | 0.15 % | $ 111 B | ||
|
Myomo
MYO
|
38.6 M | $ 0.68 | -2.9 % | $ 28.5 M | ||
|
Butterfly Network
BFLY
|
256 M | $ 4.05 | -1.94 % | $ 857 M | ||
|
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | ||
|
Nevro Corp.
NVRO
|
554 M | - | - | $ 217 M | ||
|
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.61 | 3.37 % | $ 38 M | ||
|
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
124 M | $ 9.67 | -0.31 % | $ 346 M | ||
|
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
43.7 B | $ 61.86 | -1.12 % | $ 91.6 B | ||
|
Alphatec Holdings
ATEC
|
791 M | $ 11.03 | 0.55 % | $ 1.66 B | ||
|
Insulet Corporation
PODD
|
3.19 B | $ 202.46 | -0.51 % | $ 14.2 B | ||
|
CONMED Corporation
CNMD
|
2.33 B | $ 34.54 | 1.35 % | $ 1.07 B |